Clear Search

Books+ Search Results

LC Class: Is
Is Is Not
K - Law
Location: Is
Is Is Not
Marx Library
Subject with Hierarchy: Is
Is Is Not
Pharmaceutical industry

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

1.
Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington, DC : United States Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.ED 8/1:117-11
Format
Books
2.
No time to wait : proposals to lower prescription drug costs : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventeenth Congress, second session, Phoenix, Arizona, April 12, 2022
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.AG 4:S.HRG.117-249
Format
Books
3.
Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Consumer Protection and Commerce, author
Published
Washington : U.S. Government Publishing Office, 2022.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-63
Format
Books
4.
Improving drug pricing transparency and lowering prices for American consumers : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 21, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-37
Format
Books
5.
Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington, DC : United States Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-32
Format
Books
6.
Lowering the cost of prescription drugs : reducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-17
Format
Books
7.
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.ED 8/1:116-42
Format
Books
8.
The SACKLER Act and other policies to promote accountability for the Sackler family's role in the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, June 8, 2021
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2021.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:117-27
Format
Books
9.
Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.F 49:S.HRG.115-727
Format
Books
10.
Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-25
Format
Books
11.
Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:116-21
Format
Books
12.
Unsustainable drug prices : hearing before the Committee on Oversight and Reform, House of Representatives
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020-2021.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-123
Format
Books
13.
Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2019-
Location
Library Shelving Facility (LSF) >> Y 4.F 49:S.HRG.116-39
Format
Books
14.
Examining implementation of the Compounding Quality Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:115-96
Format
Books
15.
Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-01
Format
Books
16.
HIV prevention drug : billions in corporate profits after millions in taxpayer investments : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, May 16, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-24
Format
Books
17.
The patient perspective : the devastating impacts of skyrocketing drug prices on American families : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, July 26, 2019
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2019.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:116-55
Format
Books
18.
Competition in the pharmaceutical supply chain : the proposed merger of CVS Health and Aetna : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, second session, February 27, 2018
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:115-28
Format
Books
19.
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2018.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.114-805
Format
Books
20.
Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
Author
United States. Congress. House. Committee on Oversight and Government Reform, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:114-132
Format
Books
21.
Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain : hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
Author
United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, Benefits, and Administrative Rules, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.G 74/7:115-33
Format
Books
22.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:114-97
Format
Books
23.
Counterfeit drugs : fighting illegal supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 27, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, author
Published
Washington : U.S. Government Publishing Office, 2015.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-120
Format
Books
24.
Examining drug compounding : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 23, 2013
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-48
Format
Books
25.
Examining drug shortages and recent efforts to address them : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 10, 2014
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office, [date of distribution not identified]
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-117
Format
Books